TheStreet's Jim Cramer is keeping an eye on CVS (CVS) and Chevron (CVX) on Friday as both companies release their latest quarterly results before the opening bell. Cramer says he's watching CVS because 'there's just so much action in the drugstore complex right now with Walgreens (WBA) trying to buy Rite Aid (RAD). CVS has been a consistent deliverer, the last quarter it did not go up though. I think that could turn, I think CVS is a great American retailer, it's also a great American healthcare company so I like that.' Analysts are expecting the company to post earnings of $1.29 a share on $37.7 billion in revenue for its third quarter. On Chevron Cramer says, 'Chevron is an incredibly honest company and I think they're going to give us both a short term and a longer term view and they're going to talk about how important it is to keep that dividend.' Analysts expect Chevron to post earnings of $0.83 a share on $31.10 billion in revenue for the quarter.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.